This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Pharmaceutical Drugs
From Proteopedia
| (7 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
[[Image: Nexium.jpg|160px|right|thumb|AstraZeneca’s Nexium]] | [[Image: Nexium.jpg|160px|right|thumb|AstraZeneca’s Nexium]] | ||
| - | The Pharmaceutical industry is one of the world’s largest industries, grossing well over $300 billion in the United States alone. Understanding how the drugs the pharma industry develops work and different characteristics of these compounds is important to nearly everyone as 50% of the US population takes at least one prescription medication regularly and nearly everyone takes a pharmaceutical pill at some point in their life.<ref>http://www.npr.org/blogs/health/2010/09/03/129626052/a-portrait-of-health-prescription-drugs-in-america</ref> The following is a growing list of pharmaceutical compounds organized by disorder. | + | The Pharmaceutical industry is one of the world’s largest industries, grossing well over $300 billion in the United States alone. Understanding how the drugs the pharma industry develops work and different characteristics of these compounds is important to nearly everyone as 50% of the US population takes at least one prescription medication regularly and nearly everyone takes a pharmaceutical pill at some point in their life.<ref>http://www.npr.org/blogs/health/2010/09/03/129626052/a-portrait-of-health-prescription-drugs-in-america</ref> See also [[WHO Model Lists of Essential Medicines]]. The following is a growing list of pharmaceutical compounds organized by disorder. |
<br /> | <br /> | ||
<br/> | <br/> | ||
See [[Pharmaceutical Drug Targets]] for a list of drug targets organized by disease. | See [[Pharmaceutical Drug Targets]] for a list of drug targets organized by disease. | ||
| + | <br /> | ||
| + | <br/> | ||
| + | The majority of all modern medicinal drugs target members of the superfamily of proteins called the [[G protein-coupled receptor|G protein-coupled receptors]] or GPCRs<ref name="howmany">PMID: 17139284</ref><ref name="pharmtrends">PMID: 21075459</ref>. | ||
==Treatments== | ==Treatments== | ||
| Line 99: | Line 102: | ||
</td> | </td> | ||
<td style="width:33%;border-width:1px; border-style:inset; text-align:center;background:#F1F2FC"> | <td style="width:33%;border-width:1px; border-style:inset; text-align:center;background:#F1F2FC"> | ||
| - | == | + | ==[[Opioids|Opioid drugs]]== |
</td> | </td> | ||
</tr> | </tr> | ||
| Line 115: | Line 118: | ||
<td style="width:33%; vertical-align:top;border-width:1px; border-style:inset"> | <td style="width:33%; vertical-align:top;border-width:1px; border-style:inset"> | ||
<div style="overflow:auto; height:200px"> | <div style="overflow:auto; height:200px"> | ||
| + | {{:Treatments:Opioid drugs}} | ||
</div> | </div> | ||
</td> | </td> | ||
Current revision
The Pharmaceutical industry is one of the world’s largest industries, grossing well over $300 billion in the United States alone. Understanding how the drugs the pharma industry develops work and different characteristics of these compounds is important to nearly everyone as 50% of the US population takes at least one prescription medication regularly and nearly everyone takes a pharmaceutical pill at some point in their life.[1] See also WHO Model Lists of Essential Medicines. The following is a growing list of pharmaceutical compounds organized by disorder.
See Pharmaceutical Drug Targets for a list of drug targets organized by disease.
The majority of all modern medicinal drugs target members of the superfamily of proteins called the G protein-coupled receptors or GPCRs[2][3].
Treatments
The following is a list of pharmaceutical treatments for various diseases, organized by disorder. Each entry highlights general information about the therapeutic, pharmacokinetic data comparisons within its drug class, and a structural analysis explaining how the drug compound functions in vivo.
Alzheimer's Disease |
Bacterial Infection |
Cancer |
|||
|
|
|
|||
Depression |
Diabetes |
Erectile Dysfunction |
|||
|
|
||||
Hypercholeseterolemia |
Hypertension |
HIV |
|||
|
|
|
|||
Inflammation & Arthritis |
Influenza |
Opioid drugs |
|||
|
|
|
References
- ↑ http://www.npr.org/blogs/health/2010/09/03/129626052/a-portrait-of-health-prescription-drugs-in-america
- ↑ Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. PMID:17139284 doi:10.1038/nrd2199
- ↑ Peeters MC, van Westen GJ, Li Q, IJzerman AP. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. Trends Pharmacol Sci. 2011 Jan;32(1):35-42. PMID:21075459 doi:10.1016/j.tips.2010.10.001
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Karsten Theis, Wayne Decatur
